GlassScriptPhysician profile
Emily Capoccia
NPI 1679057715
$1,005.78
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $689 · 2022: $316.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $222.55 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $201.68 | 2021-2022 | |
| Novo Nordisk INC | $164.25 | 2021-2022 | |
| Redhill Biopharma INC. | $103.69 | 2021 | |
| Ethicon US, LLC | $101.12 | 2021-2022 | |
| Intuitive Surgical, INC. | $95.65 | 2021 | |
| W. L. Gore & Associates, INC. | $50.66 | 2021 | |
| Intra-Sana Laboratories | $32.55 | 2021 | |
| Acacia Pharma INC | $21.55 | 2021 | |
| Teleflex LLC | $12.08 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Capoccia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.